DESIRIAL® is the first gel based on antioxidant hyaluronic acid specially formulated to preserve the intimate health of women .
Entirely dedicated to women's intimate health, the DESIRIAL® viscosupplementation solution developed by Laboratoires Vivacy opens up new treatment options in gynecology and intimate plastic surgery.
Up to 80% of women who enter menopause are affected by vaginal dryness and approximately 50% of postmenopausal women continue to experience vaginal dryness.
Vaginal and/or vulvar dryness can affect women throughout their lives, whether iatrogenic (eg isotretinoin, tricyclic antidepressants, neuroleptics, etc.), or related to menopause, in particular in the absence of hormone replacement therapy (HRT).
During menopause, a decrease in estrogen secretion is observed, which has an effect on the fibroblasts, and leads to a progressive hypotrophy of the dermis with the flattening of the dermo-epidermal junction:
- The vaginal mucosa becomes dry (the connective tissue has less vascularization, is less hydrated and becomes thinner), just like the skin as a whole. Less nourished glandular cells become trophic and begin to malfunction.
- The skin loses its elasticity. Collagen and elastin fibers degenerate and shrink, fibroblasts become hypoactive and type III collagen increases at the expense of type I collagen.
As a result, skin dryness, loss of elasticity, and fragility appear. Falling estrogen levels (related to menopause) leads to labia majora hypotrophy, also characterized by dryness of the vulva.
The injection of DESIRIAL® cross-linked hyaluronic acid into the dermis of the lip can help rehydrate, biostimulate and restore the activity of fibroblasts and maintain the proper functioning of female genital tissues.
DESIRIAL®:
for women in the pre-menopausal period or of reproductive age with a predisposition or clear signs of moderate to severe hypotrophy of the vulva and labia majora.
Remodeling of the labia majora, the vulva.
| DESIRIAL STYLING | |
| Composition | Cross-linked hyaluronic acid + Antioxidant + Sodium hyaluronate, mannitol |
| Concentration | 19mg/g |
| volumes | 2 x 1ml |
| Needles | 27G 1/2 |
| Directions | Medium to deep wrinkles |
| Storage | 2°C to 25°C |
| Afterglow | 12 months |
- 2 pre-filled syringes of 1ml Needles 27G1/2
- Composed of a cross-linked hyaluronic acid concentrated at 19mg/g
- IPN-Like technology which extends its duration of action
- Hyaluronic Acid stimulates the natural hydration of the skin over the long term
DESIRIAL® was created to restore hydration, elasticity, tone1 and sensitivity to the vulvo-vaginal2 area. This hyaluronic acid gel is directly injected into the tissues that need it. It helps to reduce the dehydration of the vaginal mucosa and strengthens the quality of the tissues.
For women in the pre-menopausal period or of reproductive age with a predisposition or overt signs of moderate to severe hypotrophy of the vulva and labia majora.
Remodeling of the labia majora, the vulva.
Reinforcement of the protective function of the labia majora through an increase in volume.
Improved aesthetic appearance of the vulvo-vaginal area
Attention ! This act must be carried out by a qualified professional.
COMPOSITION
INDICATION
FOR WHAT?
Rehydration and biostimulation of the skin and mucous membranes to increase collagen synthesis by stimulating fibroblasts.
The objective is to soften and moisturize the tissues for a long time.
FOR WHO?
INDICATION
RESULTS
